Description
The new RTR+ upgraded Septodont bone substitute replaces the original RTR syringe. This biphasic (B-TCP/HA) allows dentists to choose and manage the pace of their bone graft procedures, supporting the creation of stable and high-quality natural bone. It is available in 2 formulations in 0.5 cc syringes for easy placement and clean up.
Features and Benefits:
- Ideal osteogenic matrix, designed through a special manufacturing process
- RTR+ 80/20 develops new bone in shorter time (3-9 months)
- RTR+ 40/60 develops new bone in longer time (9-12 months)
- Gives a micro & macroporous structure that mimics human bone
- Offers high success rate with no risk of disease
- Hydroxyapatite and Beta Tricalcium Phosphate are both fully resorbable and will gradually produce new bone